ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 27 5 2020
medline: 4 9 2020
entrez: 27 5 2020
Statut: ppublish

Résumé

To determine mortality rates among adults with critical illness from coronavirus disease 2019. Observational cohort study of patients admitted from March 6, 2020, to April 17, 2020. Six coronavirus disease 2019 designated ICUs at three hospitals within an academic health center network in Atlanta, Georgia, United States. Adults greater than or equal to 18 years old with confirmed severe acute respiratory syndrome-CoV-2 disease who were admitted to an ICU during the study period. None. Among 217 critically ill patients, mortality for those who required mechanical ventilation was 35.7% (59/165), with 4.8% of patients (8/165) still on the ventilator at the time of this report. Overall mortality to date in this critically ill cohort is 30.9% (67/217) and 60.4% (131/217) patients have survived to hospital discharge. Mortality was significantly associated with older age, lower body mass index, chronic renal disease, higher Sequential Organ Failure Assessment score, lower PaO2/FIO2 ratio, higher D-dimer, higher C-reactive protein, and receipt of mechanical ventilation, vasopressors, renal replacement therapy, or vasodilator therapy. Despite multiple reports of mortality rates exceeding 50% among critically ill adults with coronavirus disease 2019, particularly among those requiring mechanical ventilation, our early experience indicates that many patients survive their critical illness.

Identifiants

pubmed: 32452888
doi: 10.1097/CCM.0000000000004457
pmc: PMC7255393
pii: 00003246-202009000-00035
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e799-e804

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI134182
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : UpdateOf
Type : CommentIn

Références

JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Am J Respir Crit Care Med. 2010 Jul 1;182(1):41-8
pubmed: 20203241
Am J Trop Med Hyg. 2020 Jun;102(6):1191-1197
pubmed: 32319424
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Chest. 2008 May;133(5):1120-7
pubmed: 18263687
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
JAMA. 2009 Nov 4;302(17):1880-7
pubmed: 19822626
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524

Auteurs

Sara C Auld (SC)

Emory Critical Care Center (ECCC), Atlanta, GA.
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA.
Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA.
Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA.
Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA.
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Department of Pathology, Emory University School of Medicine, Atlanta, GA.
Emory University Hospital, Emory Healthcare, Atlanta, GA.
Department of Surgery, Emory University School of Medicine, Atlanta, GA.
Office of Quality and Risk, Emory Healthcare, Atlanta, GA.

Mark Caridi-Scheible (M)

Emory Critical Care Center (ECCC), Atlanta, GA.
Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA.

James M Blum (JM)

Emory Critical Care Center (ECCC), Atlanta, GA.
Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA.
Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA.
Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA.

Chad Robichaux (C)

Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA.
Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA.

Colleen Kraft (C)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Department of Pathology, Emory University School of Medicine, Atlanta, GA.

Jesse T Jacob (JT)

Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA.
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.

Craig S Jabaley (CS)

Emory Critical Care Center (ECCC), Atlanta, GA.
Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA.

David Carpenter (D)

Emory Critical Care Center (ECCC), Atlanta, GA.

Roberta Kaplow (R)

Emory University Hospital, Emory Healthcare, Atlanta, GA.

Alfonso C Hernandez-Romieu (AC)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.

Max W Adelman (MW)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.

Greg S Martin (GS)

Emory Critical Care Center (ECCC), Atlanta, GA.
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA.

Craig M Coopersmith (CM)

Emory Critical Care Center (ECCC), Atlanta, GA.
Department of Surgery, Emory University School of Medicine, Atlanta, GA.

David J Murphy (DJ)

Emory Critical Care Center (ECCC), Atlanta, GA.
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Office of Quality and Risk, Emory Healthcare, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH